Technical writing for regulatory submissions, including CER, STED, and eSTAR formatting
The structured authoring and formatting of technical dossiers that demonstrate a medical device's safety, efficacy, and compliance to global regulatory bodies like the FDA and EU MDR, using specific, mandatory templates.
This skill is the primary gatekeeper for commercial market access; a flawed submission directly delays or blocks product launches, costing millions in lost revenue and eroding stakeholder confidence. Mastery ensures a predictable, audit-proof pathway through regulatory review, securing the company's legal right to sell.
1Careers
1Categories
9.1 Avg Demand
15%
Avg AI Risk
How to Learn Technical writing for regulatory submissions, including CER, STED, and eSTAR formatting
1. Master the 'language': Study EU MDR (2017/745) Annex I (General Safety and Performance Requirements) and FDA 21 CFR 814. Understand the purpose of a CER (Clinical Evaluation Report) per MEDDEV 2.7/1 Rev 4 and MDR Article 61. 2. Deconstruct a template: Obtain a standard STED (Summary Technical Documentation) or eSTAR template. Annotate every section heading, identifying what data it expects. 3. Build a personal glossary: Define terms like 'clinical benefit', 'state of the art', 'literature search protocol', and 'PMCF' (Post-Market Clinical Follow-up).
1. Shift from 'what' to 'how': Practice constructing a narrative that links pre-clinical data, clinical investigation results, and post-market surveillance data into a coherent risk-benefit argument. 2. Master the traceability matrix: Create a document that explicitly maps each piece of evidence to a specific GSPR or regulatory requirement. This is non-negotiable for auditors. 3. Common Mistake to Avoid: Never write in isolation. Regulatory writing is cross-functional; failing to integrate inputs from R&D, Quality, and Clinical Affairs creates fatal gaps and internal conflict.
1. Strategic Alignment: Architect the entire submission strategy, deciding which data goes into the CER versus the STED to pre-empt likely Notified Body or FDA reviewer questions. 2. Lead the defense: Develop the ability to stand before a regulatory agency and defend the scientific and statistical rationale in your document, especially concerning clinical evidence sufficiency. 3. Mentorship: Train junior writers on the 'why' behind the formatting rules, transforming them from form-fillers into critical thinkers who understand the regulatory philosophy.
Practice Projects
Beginner
Project
STED Section Completion for a Hypothetical Glucose Monitor
Scenario
You have the design verification test reports for a new, simple Class II blood glucose monitor. Your task is to populate Section 1 (Device Description) and Section 5 (Design Verification and Validation Summary) of a STED template.
How to Execute
1. Obtain a blank STED template (e.g., from IMDRF). 2. Use the provided test reports to populate the device description with intended use, principles of operation, and key specifications. 3. Summarize the V&V test results (accuracy, precision, sterility) in a tabular format within the designated STED section, ensuring each result is traceable to its source report. 4. Write a 1-paragraph conclusion that ties the verification data directly to the device's intended performance claims.
Intermediate
Project
Literature Search Protocol and CER Draft for an Orthopedic Implant
Scenario
The company's new hip implant (Class III) has completed its pivotal clinical trial. You must draft the literature review section of the CER, including a defensible search protocol, to establish the state of the art and compare your device's performance to competitors.
How to Execute
1. Draft a PICO-based search protocol (Population, Intervention, Comparator, Outcomes) using MEDLINE/PubMed, EMBASE, and Cochrane databases. 2. Execute the search, screen titles/abstracts, and perform full-text review against predefined inclusion/exclusion criteria. 3. Extract key safety and performance data from the included literature (competitor devices, historical controls). 4. Draft the CER literature review section, explicitly discussing the strengths and limitations of the evidence and defining the 'state of the art' for this device type.
Advanced
Case Study/Exercise
Leading a eSTAR Submission Audit Response
Scenario
The FDA has issued a Refuse to Accept (RTA) notice for your new software-based SaMD (Software as a Medical Device), citing inadequate cybersecurity documentation in the eSTAR submission. You must lead the cross-functional team to prepare a complete response within 30 days.
How to Execute
1. Convene a war-room meeting with R&D, Cybersecurity, and Quality to dissect the RTA letter, identifying the exact gaps against FDA's Premarket Cybersecurity Guidance. 2. Direct R&D to generate the missing technical artifacts (e.g., threat modeling, Software Bill of Materials - SBOM). 3. Author the new cybersecurity management report and integrate it into the correct eSTAR section, ensuring formatting compliance. 4. Draft the formal response letter, using a point-by-point counter to the RTA findings, and oversee a final QA review before resubmission.
Tools & Frameworks
Regulatory Templates & Standards
IMDRF STED TemplateFDA eSTAR TemplateEU MDR Annex II (Technical Documentation)
These are the mandatory structural blueprints. The eSTAR is an interactive, form-based template for the FDA. The STED and MDR Annex II provide the logical framework for assembling evidence for global markets, particularly the EU.
Evidence Management & Writing Tools
Endnote/Zotero (Bibliography Mgmt)Adobe Acrobat Pro (PDF Editing & Compliance)SharePoint/Document Control Systems
Endnote manages the vast literature databases for CERs. Acrobat is critical for final document assembly, hyperlinking, and ensuring the eSTAR PDF meets FDA's technical specifications. Document control systems enforce version history and audit trails.
These are the 'bibles' that dictate the scientific rigor required. They provide the methodology for literature searches, clinical evaluation, and the criteria for what constitutes valid clinical evidence for your specific risk class.
Interview Questions
Answer Strategy
Do not give a generic answer about 'improving the writing'. The interviewer wants to see your mastery of the regulatory process under pressure. Your strategy must show a return to first principles. Sample Answer: 'First, I would isolate the specific GSPRs cited in the Non-Conformity. My team would then re-map every single piece of existing clinical and pre-clinical evidence directly to those GSPRs. If gaps remain, we would initiate a targeted literature search or a post-market clinical follow-up study, per MEDDEV 2.7/1. The revised CER would include a new, clear traceability matrix as an appendix, explicitly closing each loop the auditor flagged. The goal is not just to rewrite, but to build an unassailable scientific argument.'
Answer Strategy
This tests leadership, risk management, and deep platform knowledge. Show you understand parallel workstreams and regulatory strategy. Sample Answer: 'I would immediately separate the workstreams. The device-focused eSTAR sections would be finalized and locked for internal review. Concurrently, I would work with the Drug Regulatory lead to establish a hard deadline for their Module 3 data, while pre-emptively drafting the device sections of the integrated summary documents using placeholder data. I would also prepare a parallel submission option: if the drug data arrives within 15 days of the target, we integrate; if not, we consider a pre-submission meeting with the FDA's OCP to discuss a staged review or a partial hold, ensuring we don't submit a knowingly deficient application.'
Careers That Require Technical writing for regulatory submissions, including CER, STED, and eSTAR formatting